Presentation Information
[2P-495]Targeting Oncogenic Stress Limits: Discovery of ACA-28 as a Selective ERK Pathway Agonist for Cancer Therapy
○Reiko Sugiura1 (1. Kindai University, Faculty of Pharmacy)
Comment
To browse or post comments, you must log in.Log in